Prelude Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Prelude Capital Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-76,274	Closed	-$2.06M	–	1634
2022 Q4	$2.06M	Buy	+76,274	New	+$2.01M	0.11%	210
2018 Q4	–	Sell	-3,818	Closed	-$101K	–	2271
2018 Q3	$101K	Buy	+3,818	New	+$86.4K	0.01%	948

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prelude Capital Management's MYOV Position: Q1 2023 in Review

Prelude Capital Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 76,274 shares — an estimated $2.06M sold.

Prelude Capital Management first reported a position in MYOV in Q3 2018 and held it in 2 quarters. The position peaked at $2.06M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Prelude Capital Management reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Prelude Capital Management sold 76,274 Myovant Sciences Ltd. shares in Q1 2023, an estimated $2.06M.
Prelude Capital Management first reported a position in Myovant Sciences Ltd. in Q3 2018 and held it in 2 quarters.
Prelude Capital Management's Myovant Sciences Ltd. position peaked at $2.06M in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.